Omnicell Reaches New 52-Week High (OMCL)

NEW YORK ( TheStreet) -- Omnicell (Nasdaq: OMCL) hit a new 52-week high Friday as it is currently trading at $17.26, above its previous 52-week high of $17.15 with 184,658 shares traded as of 1:11 p.m. ET. Average volume has been 185,700 shares over the past 30 days.

Omnicell has a market cap of $527.6 million and is part of the technology sector and computer hardware industry. Shares are up 10.7% year to date as of the close of trading on Thursday.

Omnicell, Inc. offers automated solutions for hospital medication dispensing and supply management primarily in the United States and Canada. The company has a P/E ratio of 113.8, equal to the average computer hardware industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your OMCL trading strategies and win cash in our stock game.

TheStreet Ratings rates Omnicell as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Omnicell Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Slide on Renewed Trade War Concerns

Stocks Slide on Renewed Trade War Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Emerging Markets Get Pounded by Global Trade Concerns

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Stocks Dive Globally as U.S.-China Trade War Intensifies

Stocks Dive Globally as U.S.-China Trade War Intensifies